The aim of the present study was to investigate the optimal timing of rLH-supplementation to improve ovarian response, embryo quality, endometrial thickness and pregnancy rate in infertile, estimated poor responders to IVF, undergoing GnRH-ant treatment. The gene discussed is GNRH1; the disease is Infertility.